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0.78, p < 0,003), TBW (r = 0.6, p < 0.03), and TBNa (r - 0.7, p < 0,001). In 
patients with high output CHF, aldosterone was not elevated but correlated 
with PRA (r = 0.8, p < 0.02) and ERPF (r = -0,75, p < 0.003). When all 
the gmupe were taken together, aldoaterone cantinued to correlate strongly 
with PRA but now a weak correlation emerged with fight atrial (r = 0.46, p 
< 0,02) and pulmonary wedge (r = 0.45, p < 0.98) pressures and cardiac 
output (r = -0,43, p < 0.03). We conclude that aldestemne is elevated In 
patients with untreated !ow but not high output CHF. It correlates weft with 
PRA in ;dl groups suggesting that PRA continues to determ~e aldesterone 
levels even in such diverse cfini(~J states but poorly with ind~oes of eait and 
water retention. 
~ Neurohumoml Activation and Hemodllution Under 
Pamntsm] AdmlnlstrM~ion o f  MolMdomine and 
Isosorbide Mononitrate 
Ids Haehnet, Andrea Beyerle~ Guentor Lehmann, Guenther Rei~er, 
Wemer Koch, Wemer Rudolph. German Heart Center Munich, Germany 
Hemnditution and neumhumoml activation folk~vAng vasodilation are thought 
to be major factors for the development of nitrate toiem.aree. To determine 
whether these mach~lisms are part of the action profile of molsidomine (M), 
we investigated the hemodynamlcs, neurohumora! activation, and hemndi- 
lution dudng i,v. administration of M and isosod~de-5-monenitrate (I) in 15 
patients with CHF (NYHA I1-111). In a randomized, double-blind, cross-over 
design, each patient received a 24-hour ;nfusion of M (6 rng/h), I (3.75 ms/h) 
and placebo (P). Measurements were gerlormed at baseline, at 2 h, at 8 h, 
end at 24 h. Resu~ (mean ± SEM): Both vasndflators caused a continuous 
increase in plasma volumes with a maximum at 24 h: I +8.2 :l: 2.2°/,, (p < 
0.0001), M +18,5 -4- 2.7% (p < 0.0001). Plasma volumes did not change on 
placebo. The plasma renln activity (ng/ml/h) is shown below: 
Baseline 2h 8h 24h 
P 7.50 ~2.37 6.954-2`29 7.82d12`17 7.53-=-2.41 
! 7.71 =~ 2.32 S.51 ~2.62 ° 10.151112.32 =~ 8.20 • 2.14 # 
M S.53 ~ 2.17 12.01 ±2A9 °=° 15.36 ~ 2.65 °°°d 12.51 ~- 2.74 **°°~ 
*p < 0.05, "p  < 0.01 (vs P), °p < 0S, °°p < 0,001 {vs baseline) #p < 0.05 (I vs M) 
Levels of Angiotensin ti, ald0stemne and vasopressin did not change 
significsntiy. Hemodyr~mtcaJly, a significant improvement of CO and diastolic 
PAP was observed at 2 h on both treatments, This effect was maln~ned on 
Mat8hand24h (p < 0.05), but not on t. 
Conclusion: Continuous infusion of ! led only to a moderate hemodilutir)n 
and noumhumorel activation, but developmem of toierence was observed 
starting at 8 h. In contrast, edministmtion of M resulted in prolonged hemo- 
dyr~mlc effects, at!hough pmn¢.,unced changes in plasma volume and nou- 
rohumorat activation occurred. We conclude '.hat tn~l  Tluid shift end/or 
neurohumoml activetiol~ is not a major factor in the development of nitrate 
tolerance. 
~ Haemodynamical Effects o f  L-Camltlne on 
Patients With Congest ive Heart Failure Due to 
Dilated Cardiomyopathy 
leannis K, RIzos, Ads!elates N, Pdmiklrepoalos, Leonidas K, Hadjlalkolaou, 
Kestes I. Kapetanios, Solids C, $lamou, Petros D, Papa~poulos, Pavlos 
K, Toutouzas. Department of Cardiology, Unk, em#y of At~.ns, Athens, 
Greece 
The haemodynamtcsl effects ol L-Camitine (LC) were studied on 34 patients 
(pts) in a double blind study. Pts with dilative cardiomyopethy (CM) and 
clinical stable heart failure (HF) (NYHA Ill-IV) wore included in the study. 
All pie underwent left and right cardiac cathetedzatien (CC) and cardiopul- 
monary exercise test (CPX) according to Weber protocol, in a baseline (BL) 
examination. After one (1M) and three months (3M) treatment ~lh placebo 
(18 pts) and LC (2 g/die per os)(16 pte) right CC and CPX were repeatod. 
All conventional drugs for HF remained unchanged dudng the study. The 
following mean values were determined prior to (b) and after Ca) CPX: max- 
imal time of CPX (CPX-T) (rain), peak 02 consumption (VO2) (ml/mtrVKg), 
artertal~utmonary blood pressure (ABP/PBP) (mmHg), cardiac output (CO) 
(L/min). 
Results: 
Ptacet~ L-camitlne 
BL 1M 3M BL 1M 3M 
CPX-T 7.2 6.8 7.0 8.2 9A* 9.5" 
VO2 12,3 11.0 11.2 13.2 1,~.3" 14,0" 
ABP(b){8/D) 128/85 133/87 131/82 127/83 115/78" 133/83 
ABP(a)(SiD) 142/96 151/94 166/96 150/92 154/95 165/95 
PBP~)(S/D) 37113 36/17 38/18 34/12 26/8" 32/12 
PBP(a)(S/D) 42/17 42/12 41114 41114 38/12 40113 
CO(b) 4.2 4.3 4.1 4.2 4.4 4.2 
CO(a) 7,8 7.9 7.8 7.0 9.5' 9,8 ° 
b-~stolic/dbslollc (S/D), "p < 0.01, p~cebo vs L-cam!line 
Conciusions: LC has improved C,O and increased the duration of CPX. V02 
was increased in one as well In 3 months alter LC administration, thereby 
improving the functional status. 
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~'~' ]  Stents in the Elderly for  Failed PTCA, Early and 
Intsmmdlate Temt Results 
Randall C. Thompson, Kirk N. GarratL Peter B. Berger, Diane Eo Gdll, David 
R, Holmes, Jr., Mayo Clinic, Jacksonville, FL: Mayo Clinic, Rochester, MN 
In order to determine relative acute and intermedtate-~'m outcomes, 113 
patients (pie) over age 65 undergoing iotresorcoa~ stem placemem for 
acute or threatened artery closure during percutenenus Uanstun~nel coronary 
engioplesty (PTCA) were compared with 74 pts < 65 y receiving stents and 
with 1,602 pts > 65 y he, ring non-emergent PTCA, 1988 through 1994. 
Compared with the younger pts end the elderly PTCA pts. the older stent 
pts hed similar important baseline chsmcteristics. The techeicat success rate 
was high in ~! three ~ ,  89,4% ek~ stent group, 93.2% younger stent 
group, 90.9% eklerly PTCA pts (p = NS) and the rate of emergency bypass 
surgew was low; 2.7%, 5.4%, and 1.1% respectively (p = NS). The rate of 
mortality for the elderly stem 10is was 4,4% vs 0% for stem pts < 65 y (p 
= 0.067) and 2.2% for PTCA pie _> 65 y (p = NS). The in-hospital MI rate 
was 3.5% for elderly stent ptevs 2.7% ter stent pts < 65 (p = NS) and 0.8% 
aldedy PTCA group Lo < 0.003). The incidence of bradycar~a was higher 
in the eldedy etent pte (11.5%) than younger stent pts (1.4%)(p < 0.01) or 
the elderly PTCA pts (4.1%)(I) < 0.001). The eldedy stent group also had 
a more frequent need for blood transfusion (25.7%) and higher incidence of 
renal insufficiency (P_.7%) vs the elderly PTCA group (6.1%, p < 0.0001 and 
0.5%, p < 0.05), 10ut not compared with the younger etent group (21.6% and 
0%, p = NS). 
Survival free of MI was high for at! three groups, 91.7% elderly stem pts, 
98.3% younger stent pts, and 90.5% elderly PTCA lots at one year. 
Thus, in pie with stenla p~aced for PTCA failure, need for blond transfusion 
and cther ~ iar  complicatfon~J were frequent but in-hespilal and interme- 
diate term event free suwhtal were excellent in the elderly and is similar to 
that of e~=dy pts undergoing PTCA without need for sterile. 
~ OutcOme of  Right Ventricular Elderly In!am!Ion in 
Patients 
Hq~tor Bueno, Ras~n I~pez-Palop, Javisr BermeJo, Jce6 
L L0pez -~,  Juan L Dek~n. Hes/~at Genera/"Gregodo .V~ra~n" 
M~,  Spain 
It is known that, among patients (10is) with inferior myocard~ infarction, those 
who develop right ventdcular infarction (RVI) have a worse prognosis, and 
that LV diastolic: dysfon.'~on is a common feature in elderly pie, in whom 
cardiac output is more debende~t on LV filling presure. Them!ore, it might 
be as t~ted  that RVI should have a pmlicuia~'ly negative e,~ent in the 
hemodycamlca of inferior AMI in eldedy tots. To confirm this hypothesis and 
to investigate its dialcaJ s ign~,  we studied the in-hospital outcome of 78 
consecutive pts > 75 years old admitted to the CCU with a first AMI of inferior 
location. We cempamcl the pie with ECG or echocardiogrephic evidence of 
RVI (n = 30, 38%) with those without RVL Baseline characteristics were 
S~,niiar in heth greups except for age, which was higher in pie with RVI (81 vo 
79 yea~ old, p = O.Ot). LV ejection fraction did not significentiy differ in both 
groups {0.47 in 10ts without RVI vs 0.43 tn pts with RVI). The most ~;ignlficsnt 
results are show~ in the table. 
